Regulation and standards

The controversial approval of a home-based DNA test kit in the UK raises eyebrows.

Metabolic bone disease is highly prevalent, and although bone turnover marker (BTM) assays have a key role to play in its diagnosis and monitoring, the lack of internationally recognized guidelines for the interpretation of patient results has limited their clinical usefulness.

IFCC President Graham Beastall offers his overarching perspective on the importance of its task forces.

Thyroid disease is a highly prevalent and severe health problem that requires timely diagnosis and disease management.

We set out on a mission when we formed the task force on chronic kidney disease (CKD) – a joint project between the IFCC and World Association of Pathology and Laboratory Medicine

A new prognostic index, combining morphological and molecular parameters, is needed to improve breast cancer guidance

Best practice guidance to ensure that molecular pathology labs get the best possible result

Processes and key considerations when conducting a molecular pathology test for cancer patients.

Matthew Burke, Perry van Rijsingen and Olga Colgan offer their perspectives on digital pathology adoption and the future of the field.

Marcial Garcia Rojo of the Hospital de Jerez de la Frontera, Cadiz, Spain, is a key proponent and early adopter of digital pathology, having used the approach for more than seven years.